Transcriptomics

Dataset Information

0

MDA-MB-231-LM2 cells treated with sudemycin D6 (SD6)

ABSTRACT: The objective is to identify gene expression patterns that occur after spliceosome inhibition in triple-negative breast cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE163411 | GEO | 2020/12/18

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics SUM159 cells treated with sudemycin D6 (SD6)
2020-12-18 | GSE163414 | GEO
Genomics MDA-MB-231-LM2 cells treated with sudemycin D6 (SD6)
| PRJNA686063 | ENA
Transcriptomics SUM159 cells treated with H3B-8800 or DMSO, Cytoplasmic fraction RNA-seq
2020-12-17 | GSE163232 | GEO
Transcriptomics T11, AT3, PyMT-M, 2208L GEMM tumors treated with H3B-8800
2020-12-17 | GSE163181 | GEO
Transcriptomics SUM159 cells treated with H3B-8800 or DMSO, J2 enrichment for dsRNA
2020-12-17 | GSE163188 | GEO
Unknown Expression data from parental MDA-MB-231 cells and MDA-MB-231(SA) variant
| S-ECPF-GEOD-20085 | biostudies-other
Proteomics Beta-Adrenergic stimulation of breast cancer MDA-MB-231 and bone tropic MDA-MB-231-BoM 1833 cell line secretome
2023-07-20 | PXD030371 | Pride
Proteomics Proteins that interact with FGD5 in MDA-MB-231
2021-02-19 | PXD024266 | iProX
Unknown Effects of FSTL1 on cell proliferation in breast cancer cell line MDA‑MB‑231 and its brain metastatic variant MDA‑MB‑231‑BR.
| S-EPMC5780039 | biostudies-literature
Unknown Citral induced apoptosis in MDA-MB-231 spheroid cells.
| S-EPMC5809808 | biostudies-literature